Editorial Comment on “Implications of Alpha Gal Syndrome in Urologic Management”

Posted by author-avatar

Publication date: Available online 12 August 2026

Source: Urology

Author(s): Hannah V. Jarvis

Read More

Newer
Editorial Comment on “Quantitative Assessment of Additive Effects Of mirabegron and Solifenacin in Overactive Bladder: Re-analysis of SYNERGY Study”
Older Pediatric Urologic Oncology Series: Surgeon Focused Update of the Changes to the New Children’s Oncology Group Study of Unilateral Favorable Histology Wilms Tumor (AREN2231)